Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Non-uterine gynecological sarcomas

  • 36 Accesses

  • 9 Citations


Sarcomas represent only 2%–3% of all female genital tract malignancies. Only 10% occur outside the uterus (vulva, vagina, ovaries, fallopian tubes, uterine ligaments). The morphology of these tumors is sometimes confusing. Sarcomas are often not diagnosed before they reach a very advanced stage. A large percentage of sarcomas occur in very young women. Treatment is not satisfactory and the prognosis has remained bad despite the use of chemotherapy for some tumors (e.g. embryonal rhabdomyosarcoma). Improvements in diagnosis and therapy require pooling of experience and the establishment of an appropriate tumor registry.

This is a preview of subscription content, log in to check access.


  1. Azoury RS, Woodruff JD (1971) Primary ovarian sarcomas. Report of 43 cases from the Emil Novak Ovarian Tumor Registry. Obstet Gynecol 37:920–941

  2. Bartl W, Riss P (1981) Zur Klinik der malignen Lymphome im Bereich des weiblichen Genitaltraktes. 3 Fallberichte. Zentralbl Gynäkol 103:708–712

  3. Bender HG (1984) Tumoren de Vulva. In: Bender HG (ed) Gynäkologische Onkologie für die Praxis. Thieme, Stuttgart New York

  4. Bitos NA, Georgakopoulos PA, Tongas J, Lawani KO (1982) Primary sarcomas of the ovary (meeting abstract) 1st Congress of the European Society of Surgical Oncology, November 26–27, 1982, Athens, Greece. European Society of Surgical Oncology, pp 336

  5. Carlson JA, Edwards C, Wharton JT, Gallager HS, Delclos L, Rutledge F (1983) Mixed mesodermal sarcoma of the ovary. Treatment with combination radiation therapy and chemotherapy. Cancer 52:1473–1477

  6. Cramer DW, Cutler SJ (1974) Incidence and histology of malingnancies of the female genital organs in the United States. Am J Obstet Gynecol 118:433–443

  7. Dallenbach-Hellweg G (1982) Hystogenetische Klassifikation. In: Dallenbach-Hellweg G (ed) Ovarialtumoren. Springer, Berlin Heidelberg New York

  8. Davos J, Abell MR (1976) Soft tissue sarcomas of vulva. Gynecol Oncol 4:70–86

  9. Davos J, Abell MR (1976) Sarcomas of the vagina. Obstet Gynecol 47:342–350

  10. DiSaia PJ, Rutledge F, Smith SP (1971) Sarcoma of the vulva. Report of 12 patients. Obstet Gynecol 38:180–184

  11. Ghavini F, Exelby PR, D'Angio GJ (1975) Multidisciplinary treatment of embryonal rhabdomyosarcomas in children. Cancer 35:677–686

  12. Hannigan EV, Freedman RS, Elder KW, Rutledge FN (1983a) Treatment of advanced uterine sarcoma with vincristine, actinomycin D and cyclophosphamide. Gynecol Oncol 15:224–229

  13. Hannigan EV, Freedman RS, Rutledge FN (1983b) Adjuvant chemotherapy in early uterine sarcoma. Gynecol Oncol 15:56–64

  14. Hay DM (1980) The management of rhabdomyosarcoma in children and young adults. World J Surg 4:15

  15. Hernandez W, DiSaia PJ, Morrow CP, Townsend DE (1977) Mixed mesodermal sarcoma of the ovary. Obstet Gynecol 49:595–635

  16. Heyn R, Holland R, Newton W, Trefft M, Breslow N, Hartmann JR (1974) The role of combined therapy in the treatment of rhabdomyosarcoma in children. Cancer 34:2128–2141

  17. Janovski NA, Paramanandhan TL (1973) Ovarian tumors. Thieme, Stuttgart

  18. Kolstad P (1981) Malignant tumors of ovary: Norwegian experience and protocols for management. In: Coppleson M (ed): Gynecologic oncology. Churchill, Livingstone Edinburgh London Melbourne New York

  19. Kumar A, Wrenn EL, Fleming ID, Hustu HO, Pratt CB (1976) Chemotherapy to prevent complete pelvic exenteration for rhabdomyosarcoma of the vagina and uterus. Cancer 37:118–122

  20. Lathrop JC (1967) Malignant pelvic lymphomas. Obstet Gynecol 30:137–145

  21. Leite C, Goodwin JW, Sinkovics JG, Baker LH, Benjamen RS (1977) Chemotherapy of fibrous histiocytoma: a southwest oncology group report. Cancer 40:2010–2014

  22. Leppien G (1986) Sarkome der weiblichen Genitalorgane. In: Wulf KH, Schmidt-Matthiesen H (eds) Klinik der Frauenheilkunde und Geburtshilfe, vol 11, 2nd edn. Urban & Schwarzenberg, München Wien Baltimore

  23. Mohr HJ, Sonntag A (1982) Zur Epidemiologie der Ovarialtumoren. In: Dallenbach-Hellweg (ed) Ovarialtumoren. Springer, Berlin Heidelberg New York

  24. Norris HJ, Roth E, Taylor HB (1966) Mesenchymal tumors of the uterus A clinical and pathologic study of thirty-one mixed mesodermal tumors. Obstet Gynecol 28:57–72

  25. O'Quinn AG, Edwards CL, Gallager HS (1982) Pseudosarcoma botryoidees of the vagina in pregnancy. Gynecol Oncol 13:237–241

  26. Schmeißer G, Schmidt U, Schirmer A (1980) Behandlungsergebnisse der primären Karzinome und Sarkome der Scheide. Zentralbl Gynäkol 102:369–373

  27. Smith JP, Day TG (1979) Review of ovarian cancer at the University of Texas, Systems Cancer Center, M.D. Anderson Hospital and Tumor Institute. Am J Obstet Gynecol 135:984–990

  28. Vonte PA, Voss A, Kraker J (1982) Primary chemotherapy treatment in children with Rhabdomyosarcoma. 17th ASCO Meeting, Washington, DC (Abstract) Proceedings 292:408

  29. Wheeler JE (1982) Pathology of the fallopian tube. In: Blaustein A (ed) Pathology of the female genital fract. Springer, Berlin, pp 393–415

  30. Wolf A, Vahrson H (1976) Zur Prognose der Genitalsarkome bei der erwachsenen Frau unter besonderer Berücksichtigung der Sarkome des Corpus uteri. Geburtshilfe Frauenheilk 36:856–861

  31. Woodruff JD (1981) Malignant nonspecific mesenchymal tumors of ovary: “ovarian sarcomas”. In: Coppleson M (ed) Gynecologic oncology. Churchill Livingstone, Edinburgh London Melbourne New York

Download references

Author information

Additional information

Dedicated to Professor H. Bredt on the occasion of his 80th birthday

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Leppien, G. Non-uterine gynecological sarcomas. Arch Gynecol Obstet 241, 25–32 (1987). https://doi.org/10.1007/BF00931437

Download citation

Key words

  • Ovary
  • Vulva
  • Vagina
  • Sarcomas